These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
771 related articles for article (PubMed ID: 28153774)
21. Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma. Endo T; Kawai K; Kamba T; Inai H; Uchida K; Miyazaki J; Kamoto T; Ogawa O; Nishiyama H Jpn J Clin Oncol; 2014 Apr; 44(4):355-9. PubMed ID: 24558127 [TBL] [Abstract][Full Text] [Related]
22. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility. Cooper DE; L'esperance JO; Christman MS; Auge BK J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661 [TBL] [Abstract][Full Text] [Related]
24. The management of testicular cancer in Victoria, 1988-1993. Urology Study Committee of the Victorian Co-operative Oncology Group. Toner GC; Neerhut GJ; Schwarz MA; Thursfield VJ; Sandeman TF; Giles GG; Snow RM Med J Aust; 2001 Apr; 174(7):328-31. PubMed ID: 11346104 [TBL] [Abstract][Full Text] [Related]
25. The Evolving Management of Patients With Clinical Stage I Seminoma. Matulewicz RS; Oberlin DT; Sheinfeld J; Meeks JJ Urology; 2016 Dec; 98():113-119. PubMed ID: 27527410 [TBL] [Abstract][Full Text] [Related]
26. Stage IIA and IIB testicular seminoma treated postorchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients. Ahmed KA; Wilder RB Int Braz J Urol; 2015; 41(1):78-85. PubMed ID: 25928512 [TBL] [Abstract][Full Text] [Related]
27. A nationwide cohort study of stage I seminoma patients followed on a surveillance program. Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686 [TBL] [Abstract][Full Text] [Related]
28. Surveillance and Radiation Therapy for Stage I Seminoma--Have We Learned From the Evidence? Glaser SM; Vargo JA; Balasubramani GK; Beriwal S Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):75-84. PubMed ID: 26700704 [TBL] [Abstract][Full Text] [Related]
29. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299 [TBL] [Abstract][Full Text] [Related]
30. Primary tumor size thresholds in stage IA testicular seminoma: Implications for adjuvant therapy after orchiectomy and survival. Azizi M; Peyton CC; Boulware DC; Gilbert SM; Sexton WJ Urol Oncol; 2020 Jan; 38(1):7.e9-7.e18. PubMed ID: 31704139 [TBL] [Abstract][Full Text] [Related]
31. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort. Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274 [TBL] [Abstract][Full Text] [Related]
32. Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility. Gray PJ; Lin CC; Sineshaw H; Paly JJ; Jemal A; Efstathiou JA Cancer; 2015 Mar; 121(5):681-7. PubMed ID: 25345675 [TBL] [Abstract][Full Text] [Related]
33. Treatment Trends for Stage I Testicular Seminoma in an Equal-Access Medical System. Wingate JT; Etzioni R; Macdonald DM; Brand TC Clin Genitourin Cancer; 2016 Oct; 14(5):438-443. PubMed ID: 26794393 [TBL] [Abstract][Full Text] [Related]
34. Management of stage I testicular seminoma over a period of 49 years. Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849 [TBL] [Abstract][Full Text] [Related]
35. Stage I testicular seminoma: results of adjuvant irradiation and surveillance. Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083 [TBL] [Abstract][Full Text] [Related]
36. Management of Stage II testicular seminoma over a period of 40 years. Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association. Kawai T; Tanaka Y; Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468 [TBL] [Abstract][Full Text] [Related]
38. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy. Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361 [TBL] [Abstract][Full Text] [Related]
39. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group. Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748 [TBL] [Abstract][Full Text] [Related]